Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
03/1996
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein
03/20/1996EP0395736B1 Purified thermostable enzyme
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
03/20/1996CN1119027A Method of controlling insects in plants
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1118983A Tomato spotted wilt virus
03/20/1996CA2158076A1 Antitumor antibiotic compounds; hayumicins and analogs thereof
03/19/1996US5500367 Stilbene synthase genes from grapevine
03/19/1996US5500365 Synthetic plant genes
03/19/1996US5500364 Pure mutants
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500361 β-ketoacyl-ACP synthetase II genes from plants
03/19/1996US5500360 RNA transformation vector
03/19/1996US5500359 Fermentation, antitumor agents
03/19/1996US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators
03/19/1996US5500347 Diagnosis of cancerous tumors and determination of their origin
03/19/1996US5500341 Nucleotide amplification primers; genetic engineering
03/19/1996CA2002515C Expression enhancer and use thereof to increase the yield in the expression of recombinant genes
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/19/1996CA1338170C Ab-011 antibiotics and process for producing them
03/19/1996CA1338169C Compounds wf 2015 a and b, production thereof and use thereof
03/19/1996CA1338168C Antibiotic ll-e19020 alpha and beta
03/17/1996CA2158395A1 Coccidiosis poultry vaccine
03/14/1996WO1996007749A2 Methods and compositions for inhibiting production of replication competent virus
03/14/1996WO1996007745A2 Mycobacteria functional screening and/or expression vectors
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007728A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996WO1996006175A3 Fumonisin-detoxifying enzymes
03/14/1996WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199419A1 Methods and compositions for inhibiting production of replication competent virus
03/14/1996CA2198928A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996CA2197888A1 Modified human c3 proteins
03/13/1996EP0701000A2 Recombinant thermostable DNA polymerase from archaebacteria
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof
03/13/1996EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma
03/13/1996EP0700991A1 Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
03/13/1996EP0700522A1 Method for selection of biologically active peptide sequences
03/13/1996EP0700446A1 Antibodies specific for dcc gene product
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700443A1 Cho cell sialidase disrupted by recombinant dna technology
03/13/1996EP0700441A1 Multiple sclerosis virus
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700433A1 A method for hydrolysing proteins
03/13/1996EP0700431A1 Proline iminopeptidase, process for its preparation and its use in the flavouring of food compositions
03/13/1996EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/13/1996EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
03/13/1996EP0617746B1 Strength loss resistant methods for improving the softening of cotton toweling and related fabrics
03/13/1996EP0567562B1 Methods for detecting glucagon antagonists
03/13/1996EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
03/13/1996EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates
03/13/1996EP0440772B1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0435911B1 Cell culture medium for enhanced cell growth, culture longevity and product expression
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/12/1996US5498697 Protein possessing metastasis-inhibitory activity
03/12/1996US5498625 Substantially pure enantieners of 2-azabicyclo(2.2.1)hept-5-en-3-one
03/12/1996US5498532 Corynbacterium or brevibacterium, recombinant dna
03/12/1996US5498526 Bacillus circulans based biological indicator for gaseous sterilants
03/12/1996US5498525 Infecting with bacteriophage
03/12/1996US5498499 Peptides and antibodies that inhibit platelet adhesion
03/12/1996CA2092402C Anticoccidial and growth promoting polycyclic ether antibiotic
03/12/1996CA1338143C Enzymatic preparation of clavulanic acid and its precursor
03/12/1996CA1338141C Process for production of avermectins and cultures therefor
03/12/1996CA1338139C Anoxic ammonia oxidation
03/12/1996CA1338138C Recombinant-dna mediated production of xanthan gum
03/10/1996CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006936A1 Nucleotides sequences of canola and soybean palmitoyl-acp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants
03/07/1996WO1996006935A2 Arabinoxylan degrading enzymes
03/07/1996WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996WO1996006932A1 Plant transcription regulators from circovirus
03/07/1996WO1996006931A1 Microbial transglutaminases, their production and use
03/07/1996WO1996006925A1 Method for increasing plasmid yield
03/07/1996WO1996006862A1 Gabaa receptor epsilon subunit
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996CA2183649A1 Method for increasing plasmid yield
03/07/1996CA2174844A1 Arabinoxylan degrading enzymes
03/06/1996EP0699904A1 Method for detecting organopathyinducing factors
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 921